Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome

被引:73
作者
Reznik, SI
Jaramillo, A
SivaSai, KSR
Womer, KL
Sayegh, MH
Trulock, EP
Patterson, GA
Mohanakumar, T [1 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal, Boston, MA 02115 USA
[5] Harvard Univ, Childrens Hosp, Sch Med, Div Renal, Boston, MA 02115 USA
关键词
CD4 T cells; chronic rejection; indirect allorecognition; lung;
D O I
10.1034/j.1600-6143.2001.001003228.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
A correlation between indirect allorecognition of mismatched donor HLA class I peptides and development of bronchiolitis obliterans syndrome (BOS) after lung transplantation has been previously observed. The aim of this study was to determine whether there was a correlation between indirect allorecognition of mismatched donor HLA class II peptides and development of BOS after lung transplantation. Peripheral blood mononuclear cells from nine BOS+ and nine BOS-lung transplant recipients were cultured with synthetic peptides corresponding to the beta-chain hypervariable region of a mismatched donor HLA-DR molecule. Then, proliferative alloreactivity as well as frequency of allo-reactive T cells were determined. In addition, the immunodominant epitopes from the donor HLA-DR molecules were identified in selected patients. T cells from BOS+ patients showed a dose-dependent proliferative alloreactivity against donor HLA-DR peptides that was significantly higher than that observed in BOS- patients (p=0.001). Similarly, the frequency of HLA-DR allo-reactive T cells was significantly higher in BOS+ patients than in BOS- patients (p=0.001). This T-cell alloreactivity was directed against a single immunodominant HLA-DR peptide. These results suggest that indirect alloreactivity to donor HLA class II molecules may play a role in the pathogenesis of BOS after lung transplantation.
引用
收藏
页码:228 / 235
页数:8
相关论文
共 46 条
[1]  
ALLEN MD, 1986, J THORAC CARDIOV SUR, V92, P449
[2]  
[Anonymous], 1991, J EXP MED, DOI DOI 10.1084/JEM.174.4.915
[3]   INDIRECT T-CELL ALLORECOGNITION OF DONOR ANTIGENS CONTRIBUTES TO THE REJECTION OF VASCULARIZED KIDNEY ALLOGRAFTS [J].
BENHAM, AM ;
SAWYER, GJ ;
FABRE, JW .
TRANSPLANTATION, 1995, 59 (07) :1028-1032
[4]   DONOR MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PEPTIDES ARE PRESENTED BY RECIPIENT MHC MOLECULES DURING GRAFT-REJECTION [J].
BENICHOU, G ;
TAKIZAWA, PA ;
OLSON, CA ;
MCMILLAN, M ;
SERCARZ, EE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) :305-308
[5]   Indirect T-cell allorecognition: Perspectives for peptide-based therapy in transplantation [J].
Benichou, G ;
Tam, RC ;
Soares, LRB ;
Fedoseyeva, EV .
IMMUNOLOGY TODAY, 1997, 18 (02) :67-71
[6]  
Benichou G, 1996, Int Rev Immunol, V13, P231, DOI 10.3109/08830189609061750
[7]  
CLERICI M, 1990, J IMMUNOL, V144, P2480
[8]  
CLUBOTARIU R, 1998, J CLIN INVEST, V101, P398
[9]  
COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713
[10]   Limiting dilution analysis: from frequencies to cellular interactions [J].
Dozmorov, I ;
Eisenbraun, MD ;
Lefkovits, I .
IMMUNOLOGY TODAY, 2000, 21 (01) :15-18